Structured Self-Talk and Wearable-Assisted Walking for Physical Activity and Function in Older Adults
Effects of Integrating Self-Talk Strategies With Wearable Technology on Physical Activity, Functional Performance, and Psychological Determinants in Community-Dwelling Older Adults: A Randomized Controlled Trial
The goal of this randomized clinical trial was to examine whether adding structured self-talk to wearable-assisted walking could support physical activity and physical function in community-dwelling older adults. The study also examined whether wearable-assisted walking provided benefits compared with a walking program without wearable feedback.
Participants were randomly assigned to one of three groups for 12 weeks: (1) wearable-assisted walking combined with structured self-talk, (2) wearable-assisted walking without structured self-talk, or (3) a walking-only active control condition. All groups followed the same moderate-intensity walking schedule.
The main questions were whether wearable-assisted walking was associated with better physical activity and functional performance than walking alone, and whether adding structured self-talk provided additional benefits beyond wearable-assisted walking. Physical activity, functional performance, and other protocol-specified health-related measures were assessed before and after the intervention.
Aperçu de l'étude
Statut
Les conditions
Description détaillée
This was a 12-week, three-arm, parallel-group randomized controlled trial conducted in community-dwelling older adults. Sixty participants were allocated in a 1:1:1 ratio to an integrated intervention group, a technology-assisted group, or an active control group.
All three groups followed the same moderate-intensity walking prescription consisting of three 30-minute sessions per week for 12 weeks, with exercise intensity guided by a rating of perceived exertion of 11-13. The integrated intervention group used a wearable activity device that provided real-time activity feedback and also received structured self-talk training. The self-talk component was designed to help participants use task-focused and motivational statements during walking and progressed from awareness and instruction to regulation and self-directed use over the intervention period.
The technology-assisted group followed the same walking prescription and used the same wearable activity device but did not receive structured self-talk training. The active control group followed the same walking prescription without wearable feedback or structured self-talk and recorded exercise participation using a paper-based log.
Assessments were conducted at baseline and after completion of the 12-week intervention. Outcome assessors were blinded to group allocation. The study was designed to distinguish the effects associated with wearable-assisted walking from any additional effects associated with adding structured self-talk.
Type d'étude
Inscription (Réel)
Phase
- N'est pas applicable
Contacts et emplacements
Lieux d'étude
-
-
臺灣省
-
Taipei, 臺灣省, Taïwan, 244
- Senior Community Activity Center
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
- Adulte plus âgé
Accepte les volontaires sains
La description
Inclusion Criteria:
-
Inclusion Criteria:
Aged 65 years or older. Community-dwelling and independent in activities of daily living. Able to ambulate safely without physical assistance; use of a cane was permitted.
Cleared for participation in moderate-intensity physical activity using the Physical Activity Readiness Questionnaire for Everyone (PAR-Q+).
Montreal Cognitive Assessment (MoCA) score of 24 or higher. Sufficient literacy and communication ability in Chinese to understand study instructions and complete study procedures.
Access to a smartphone and an internet connection. Able to independently perform basic smartphone and wearable-device operations, including charging the wearable device.
Willing to wear the study wearable device and comply with the intervention procedures.
Exclusion Criteria:
A medically treated fall within the previous 3 months. A major cardiovascular event within the previous 6 months. Lower-extremity surgery within the previous 6 months. Severe neuromuscular disease that could interfere with safe participation or outcome assessment.
Severe visual or auditory impairment that could interfere with communication or study assessments.
Use of medications known to substantially affect cognitive function or muscle performance.
Concurrent participation in another structured exercise or rehabilitation program.
A medical contraindication to moderate-intensity exercise, including unstable chronic medical conditions as determined by a healthcare professional.
Severe psychiatric disorder or cognitive impairment that could interfere with adherence to study procedures.
Exclusion Criteria:
-
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Autre
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Seul
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Integrated Intervention Group
Participants received a 12-week moderate-intensity walking program combined with wearable-based activity feedback and structured self-talk training.
Walking was prescribed three times per week for 30 minutes per session at a rating of perceived exertion of 11-13.
The wearable device provided real-time step feedback and haptic alerts.
Structured self-talk training was provided weekly and progressed through awareness, acquisition, regulation, and maintenance stages.
|
Participants performed moderate-intensity walking three times per week for 30 minutes per session over 12 weeks.
Exercise intensity was prescribed at a rating of perceived exertion (RPE) of 11-13.
This standardized walking program was provided to participants in all three study groups.
A wrist-worn wearable activity device was used to provide real-time step feedback and haptic vibration alerts during the 12-week walking intervention.
The device was used as a behavioral feedback tool to support walking participation.
Data from the intervention wearable device were not used as the research outcome measure.
Participants received weekly structured self-talk training throughout the 12-week intervention.
The training was delivered by trained instructors and progressed through four stages: awareness, acquisition, regulation, and maintenance.
Participants were taught to use structured motivational and instructional self-talk during walking and in response to wearable-generated feedback.
Standardized scripts and fidelity checklists were used to support consistent intervention delivery.
|
|
Comparateur actif: Technology-Assisted Group
Participants received the same 12-week moderate-intensity walking program and used the same wearable device for real-time activity feedback but did not receive structured self-talk training.
Brief weekly contacts were limited to device operation, battery status, and wearing compliance and did not include psychological strategy training.
|
Participants performed moderate-intensity walking three times per week for 30 minutes per session over 12 weeks.
Exercise intensity was prescribed at a rating of perceived exertion (RPE) of 11-13.
This standardized walking program was provided to participants in all three study groups.
A wrist-worn wearable activity device was used to provide real-time step feedback and haptic vibration alerts during the 12-week walking intervention.
The device was used as a behavioral feedback tool to support walking participation.
Data from the intervention wearable device were not used as the research outcome measure.
|
|
Comparateur actif: Active Control Group
Participants received the same 12-week moderate-intensity walking program without wearable-based activity feedback or structured self-talk training.
Participants recorded the date, duration, and rating of perceived exertion of each walking session using a paper-based exercise log.
|
Participants performed moderate-intensity walking three times per week for 30 minutes per session over 12 weeks.
Exercise intensity was prescribed at a rating of perceived exertion (RPE) of 11-13.
This standardized walking program was provided to participants in all three study groups.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Change in Time Spent in Moderate-to-Vigorous Physical Activity
Délai: Baseline and 12 weeks
|
Time spent in moderate-to-vigorous physical activity was assessed using a research-grade ActiGraph triaxial accelerometer during 7-day monitoring periods at baseline and after the 12-week intervention.
|
Baseline and 12 weeks
|
|
Average Daily Step Count
Délai: Baseline and 12 weeks
|
Average daily step count was measured using a research-grade ActiGraph triaxial accelerometer worn on the non-dominant wrist.
Daily steps were summarized across valid monitoring days at baseline and after the 12-week intervention.
Higher values indicate greater daily physical activity.
|
Baseline and 12 weeks
|
|
Five-Times Sit-to-Stand
Délai: Baseline and 12 weeks
|
Lower-extremity functional performance was assessed using the five-times sit-to-stand test.
Completion time was recorded in seconds, with shorter times indicating better performance.
|
Baseline and 12 weeks
|
|
Handgrip Strength
Délai: Baseline and 12 weeks
|
Upper-extremity muscle strength was assessed using dominant-hand grip strength.
Strength was recorded in kilograms, with higher values indicating greater grip strength.
|
Baseline and 12 weeks
|
|
Timed Up and Go
Délai: Baseline and 12 weeks
|
Dynamic balance and mobility were assessed using the Timed Up and Go test.
Completion time was recorded in seconds, with shorter times indicating better performance.
|
Baseline and 12 weeks
|
|
Appendicular Skeletal Muscle Mass Index
Délai: Baseline and 12 weeks
|
Appendicular skeletal muscle mass index (ASMI) was assessed using an InBody 370S bioelectrical impedance analyzer and calculated as appendicular skeletal muscle mass divided by height squared (kg/m²).
Higher values indicate greater appendicular muscle mass relative to height.
|
Baseline and 12 weeks
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Exercise Self-Efficacy
Délai: Baseline and 12 weeks
|
Exercise self-efficacy was assessed using the Exercise Self-Efficacy Scale (ESES), which evaluates confidence in continuing exercise under challenging situations.
Higher scores indicate greater exercise self-efficacy.
|
Baseline and 12 weeks
|
|
Exercise Motivation / Behavioral Regulation
Délai: Baseline and 12 weeks
|
Exercise motivation and internalization were assessed using a behavioral regulation in exercise questionnaire to evaluate the degree of autonomous motivation toward exercise.
|
Baseline and 12 weeks
|
Collaborateurs et enquêteurs
Parrainer
Les enquêteurs
- Chercheur principal: CHENG-EN WU, phd, National Taiwan College of Performing Arts
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- IRB115-029-BA
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Description du régime IPD
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .